(MedPage Today) — A compounded form of imiquimod, a topical immune response-modifying therapy approved for basal cell carcinoma and other conditions, showed promise as a treatment for ocular surface malignancies in a small case series.
In five…
Private member bill seeks to establish central optical devices quality control and vision care regulation
The proposed bill seeks to offer remedy to the alleged vulnerability of consumers who according to the bill are in a “no-man’s...






